Mechanism and prediction of HCC development in HBV infection

被引:33
作者
Xu, Weiqi [1 ]
Yu, Jun [1 ,2 ]
Wong, Vincent Wai-Sun [1 ,2 ]
机构
[1] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
关键词
Hepatocellular carcinoma; Liver cirrhosis; Liver fibrosis; Chronic hepatitis B; Entecavir; HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA DEVELOPMENT; GENOME-WIDE ASSOCIATION; X PROTEIN; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; RISK SCORES; NONINVASIVE ASSESSMENT; STIFFNESS MEASUREMENT; MUTATIONAL LANDSCAPE;
D O I
10.1016/j.bpg.2017.04.011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic hepatitis B virus (HBV) infection remains one of the leading causes of hepatocellular carcinoma (HCC) globally. Over the past few decades, the risk factors of HCC in patients with chronic hepatitis B have been well characterized, and can be divided into host and viral factors. A few groups have also derived and validated HCC prediction scores based on these risk factors. In general, the scores have high negative predictive value in identifying a low risk group who may not need HCC surveillance in the next 3-5 years. The scores have been tested originally in Asian patients, and results on their performance in the Caucasian population are conflicting. Furthermore, new research has identified genetic factors and new virological markers (e.g. hepatitis B surface antigen and core-related antigen levels) for HCC, but they are yet to be applied in routine clinical practice. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:291 / 298
页数:8
相关论文
共 130 条
  • [1] The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection
    Abu-Amara, Mahmoud
    Cerocchi, Orlando
    Malhi, Gurtej
    Sharma, Suraj
    Yim, Colina
    Shah, Hemant
    Wong, David K.
    Janssen, Harry L. A.
    Feld, Jordan J.
    [J]. GUT, 2016, 65 (08) : 1347 - 1358
  • [2] Acharya SK, 2006, NATL MED J INDIA, V19, P203
  • [3] Genomic Portrait of Resectable Hepatocellular Carcinomas: Implications of RB1 and FGF19 Aberrations for Patient Stratification
    Ahn, Sung-Min
    Jang, Se Jin
    Shim, Ju Hyun
    Kim, Deokhoon
    Hong, Seung-Mo
    Sung, Chang Ohk
    Baek, Daehyun
    Haq, Farhan
    Ansari, Adnan Ahmad
    Lee, Sun Young
    Chun, Sung-Min
    Choi, Seongmin
    Choi, Hyun-Jeung
    Kim, Jongkyu
    Kim, Sukjun
    Hwang, Shin
    Lee, Young-Joo
    Lee, Jong-eun
    Jung, Wang-rim
    Jang, Hye Yoon
    Yang, Eunho
    Sung, Wing-Kin
    Lee, Nikki P.
    Mao, Mao
    Lee, Charles
    Zucman-Rossi, Jessica
    Yu, Eunsil
    Lee, Han Chu
    Kong, Gu
    [J]. HEPATOLOGY, 2014, 60 (06) : 1972 - 1982
  • [4] Molecular cloning of a rat chromosome putative recombinogenic sequence homologous to the hepatitis B virus encapsidation signal
    Aoki, H
    Kajino, K
    Arakawa, Y
    Hino, O
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (14) : 7300 - 7304
  • [5] Baig S, 2009, JCPSP-J COLL PHYSICI, V19, P598, DOI 09.2009/JCPSP.598600
  • [6] The hepatitis B virus X protein enhances the DNA binding potential and transcription efficacy of bZip transcription factors
    Barnabas, S
    Hai, TW
    Andrisani, OM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (33) : 20684 - 20690
  • [7] Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function
    Belloni, Laura
    Pollicino, Teresa
    De Nicola, Francesca
    Guerrieri, Francesca
    Raffa, Giuseppina
    Fanciulli, Maurizio
    Raimondo, Giovanni
    Levrero, Massimo
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (47) : 19975 - 19979
  • [8] The enigmatic X gene of hepatitis B virus
    Bouchard, MJ
    Schneider, RJ
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (23) : 12725 - 12734
  • [9] SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA
    BRESSAC, B
    KEW, M
    WANDS, J
    OZTURK, M
    [J]. NATURE, 1991, 350 (6317) : 429 - 431
  • [10] Management of Hepatocellular Carcinoma: An Update
    Bruix, Jordi
    Sherman, Morris
    [J]. HEPATOLOGY, 2011, 53 (03) : 1020 - 1022